Literature DB >> 10753129

Managing status epilepticus. New drug offers real advantages.

M T Heafield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10753129      PMCID： PMC1117894          DOI： 10.1136/bmj.320.7240.953

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  Status epilepticus.

Authors:  D H Lowenstein; B K Alldredge
Journal:  N Engl J Med       Date:  1998-04-02       Impact factor: 91.245

Review 2.  Tonic clonic status epilepticus.

Authors:  S Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

3.  Current concepts in neurology: management of status epilepticus.

Authors:  A V Delgado-Escueta; C Wasterlain; D M Treiman; R J Porter
Journal:  N Engl J Med       Date:  1982-06-03       Impact factor: 91.245

4.  Intramuscular fosphenytoin (Cerebyx) in patients requiring a loading dose of phenytoin.

Authors:  R E Ramsay; B J Wilder; B M Uthman; W R Garnett; J M Pellock; G L Barkley; I E Leppik; L E Knapp
Journal:  Epilepsy Res       Date:  1997-10       Impact factor: 3.045

Review 5.  Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.

Authors:  L E Knapp; A R Kugler
Journal:  J Child Neurol       Date:  1998-10       Impact factor: 1.987

Review 6.  Intramuscular use of fosphenytoin: an overview.

Authors:  B M Uthman; B J Wilder; R E Ramsay
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

Review 7.  Intravenous administration of fosphenytoin: options for the management of seizures.

Authors:  R E Ramsay; J DeToledo
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

8.  Venous irritation related to intravenous administration of phenytoin versus fosphenytoin.

Authors:  B D Jamerson; G E Dukes; K L Brouwer; K H Donn; J A Messenheimer; J R Powell
Journal:  Pharmacotherapy       Date:  1994 Jan-Feb       Impact factor: 4.705
  8 in total
  1 in total

Review 1.  Emergency department drug therapy for status epilepticus in adults.

Authors:  A S Lockey
Journal:  Emerg Med J       Date:  2002-03       Impact factor: 2.740
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.